Related Content
Search Google Scholar for:
|
|
Science 15 April 1988: Vol. 240. no. 4850, pp. 336 - 338 DOI: 10.1126/science.3281260
|
|
Articles
Science, Vol 240, Issue 4850, 336-338
Copyright © 1988 by American Association for the Advancement of Science
Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria
JC Sadoff,
WR Ballou,
LS Baron,
WR Majarian,
RN Brey,
WT Hockmeyer,
JF Young,
SJ Cryz,
J Ou,
GH Lowell,
and
al. et
Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307-5100.
Immunization with radiation-attenuated malaria sporozoites induces potent cellular immune responses, but the target antigens are unknown and have not previously been elicited by subunit vaccines prepared from the circumsporozoite (CS) protein. A method is described here for inducing protective cell-mediated immunity to sporozoites by immunization with attenuated Salmonella typhimurium transformed with the Plasmodium berghei CS gene. These transformants constitutively express CS antigens and, when used to immunize mice orally, colonize the liver, induce antigen-specific cell-mediated immunity, and protect mice against sporozoite challenge in the absence of antisporozoite antibodies. These data indicate that the CS protein contains T cell epitopes capable of inducing protective cell-mediated immunity, and emphasize the importance of proper antigen presentation in generating this response. Analogous, orally administered vaccines against human malaria might be feasible.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Two Decades of Commitment to Malaria Vaccine Development: GlaxoSmithKline Biologicals.
- W. R. Ballou and C. P. Cahill (2007)
Am J Trop Med Hyg
77, 289-295
| Abstract »
| Full Text »
| PDF »
- Enhanced Immunity to Plasmodium falciparum Circumsporozoite Protein (PfCSP) by Using Salmonella enterica Serovar Typhi Expressing PfCSP and a PfCSP-Encoding DNA Vaccine in a Heterologous Prime-Boost Strategy.
- M. Chinchilla, M. F. Pasetti, S. Medina-Moreno, J. Y. Wang, O. G. Gomez-Duarte, R. Stout, M. M. Levine, and J. E. Galen (2007)
Infect. Immun.
75, 3769-3779
| Abstract »
| Full Text »
| PDF »
- Oral Immunization with a Recombinant Malaria Protein Induces Conformational Antibodies and Protects Mice against Lethal Malaria.
- L. Wang, L. Kedzierski, S. L. Wesselingh, and R. L. Coppel (2003)
Infect. Immun.
71, 2356-2364
| Abstract »
| Full Text »
| PDF »
- Expression of the Plasmodium falciparum Immunodominant Epitope (NANP)4 on the Surface of Salmonella enterica Using the Autotransporter MisL.
- F. Ruiz-Perez, R. Leon-Kempis, A. Santiago-Machuca, G. Ortega-Pierres, E. Barry, M. Levine, and C. Gonzalez-Bonilla (2002)
Infect. Immun.
70, 3611-3620
| Abstract »
| Full Text »
| PDF »
- Construction of a tetR-Integrated Salmonella enterica Serovar Typhi CVD908 Strain That Tightly Controls Expression of the Major Merozoite Surface Protein of Plasmodium falciparum for Applications in Human Vaccine Production.
- F. Qian and W. Pan (2002)
Infect. Immun.
70, 2029-2038
| Abstract »
| Full Text »
| PDF »
- Tetanus Toxin Fragment C Expressed in Live Salmonella Vaccines Enhances Antibody Responses to Its Fusion Partner Schistosoma haematobium Glutathione S-Transferase.
- J. J. Lee, K. A. Sinha, J. A. Harrison, R. D. de Hormaeche, G. Riveau, R. J. Pierce, A. Capron, R. A. Wilson, and C. M. A. Khan (2000)
Infect. Immun.
68, 2503-2512
| Abstract »
| Full Text »
| PDF »
- The Cytotoxic T-Lymphocyte Epitope of the Plasmodium falciparum Circumsporozoite Protein Also Modulates the Efficiency of Receptor-Ligand Interaction with Hepatocytes.
- D. Rathore and T. F. McCutchan (2000)
Infect. Immun.
68, 740-743
| Abstract »
| Full Text »
| PDF »
- Vaccine therapy for cancer—fact or fiction?.
- T.R.J. Evans and S.B. Kaye (1999)
QJM
92, 299-307
| Full Text »
| PDF »
- Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-{beta}1 gene therapy using attenuated Salmonella typhimurium as gene carrier.
- M L Huggins, F-P Huang, D Xu, G Lindop, and D I Stott (1999)
Lupus
8, 29-38
| Abstract »
| PDF »
- Genetic Control of Immune Response to Recombinant Antigens Carried by an Attenuated Salmonella typhimurium Vaccine Strain: Nramp1 Influences T-Helper Subset Responses and Protection against Leishmanial Challenge.
- S.-S. Soo, B. Villarreal-Ramos, C. M. A. Khan, C. E. Hormaeche, and J. M. Blackwell (1998)
Infect. Immun.
66, 1910-1917
| Abstract »
| Full Text »
| PDF »
- Mice Are Protected from Helicobacter pylori Infection by Nasal Immunization with Attenuated Salmonella typhimurium phoPc Expressing Urease A and B Subunits.
- I. E. Corthesy-Theulaz, S. Hopkins, D. Bachmann, P. F. Saldinger, N. Porta, R. Haas, Y. Zheng-Xin, T. Meyer, H. Bouzourene, A. L. Blum, et al. (1998)
Infect. Immun.
66, 581-586
| Abstract »
| Full Text »
| PDF »
- Anchoring of an Immunogenic Plasmodium falciparum Circumsporozoite Protein on the Surface of Dictyostelium discoideum.
- C. D. Reymond, C. Beghdadi-Rais, M. Roggero, E. A. Duarte, C. Desponds, M. Bernard, D. Groux, H. Matile, C. Bron, G. Corradin, et al. (1995)
J. Biol. Chem.
270, 12941-12947
| Abstract »
| Full Text »
| PDF »
- Malaria vaccines: multiple targets.
- R. Nussenzweig and C. Long (1994)
Science
265, 1381-1383
| PDF »
- Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein.
- S Khusmith, Y Charoenvit, S Kumar, M Sedegah, R. Beaudoin, and S. Hoffman (1991)
Science
252, 715-718
| Abstract »
| PDF »
- Limited immunological recognition of critical malaria vaccine candidate antigens.
- M. Good, L. Miller, S Kumar, I. Quakyi, D Keister, J. Adams, B Moss, J. Berzofsky, and R Carter (1988)
Science
242, 574-577
| Abstract »
| PDF »
- AN INNOVATIVE ORAL MALARIA VACCINE.
- (1988)
Journal Watch (General)
1988, 9
| Full Text »
|
|